This T32 Training Grant has focused successfully over the past 30 years on providing a dynamic research training environment for pathologists, other physician-scientists and basic scientists working in the molecular pathology of cancer. Over the past two 5-year funding periods, trainees have published a considerable number of papers, including in high quality journals, and have found faculty positions in prestigious medical schools. The present proposal features 20 Harvard Medical School and Massachusetts Institute of Technology faculty who are centered in the Massachusetts General Hospital Molecular Pathology Unit and Center for Cancer Research. This interactive, overlapping community of scientists and physician-scientists is organized into thematic programs in cancer genetics;animal models of cancer;mechanisms of gene expression and protein folding;cell cycle control and DNA damage repair;stem cell biology;and in vivo imaging for cancer biology and diagnosis. As in previous cycles, the trainees will be selected from a competitive pool of MD, MD-PhD and PhD applicants on the basis of prior academic and research achievements and evidence of a strong commitment to a career in cancer biology. The period of training will be two or three years for each successful applicant. An active and program-specific recruitment and retention program to enhance diversity ensures that diverse applicants have access to, and succeed in, the training program. In summary, the proposed T32 program renewal capitalizes on a highly interactive, experienced and focused faculty;a distinguished record of training productive physicians and scientists, including underrepresented minorities;state-of-the- art facilities and educational resources;and exposure of the trainees to basic and translational aspects of cancer biology.
Cancer remains a major cause of morbidity and mortality in the United States, and new approaches to the diagnosis and treatment of cancer are therefore necessary. This T32 program focuses on the training of physician-scientists and scientists who plan research careers that will improve our understanding of the molecular basis of human cancers. The program is based on the translational and basic science strengths of a Pathology department and a Cancer Center, and thus creates a dynamic platform to educate physician-scientists and scientists in the study of cancer biology.
|Berger, A H; Imielinski, M; Duke, F et al. (2014) Oncogenic RIT1 mutations in lung adenocarcinoma. Oncogene 33:4418-23|
|Masia, Ricard; Peyton, Stephen; Lauwers, Gregory Y et al. (2014) Gastrointestinal biopsy findings of autoimmune enteropathy: a review of 25 cases. Am J Surg Pathol 38:1319-29|
|Imielinski, Marcin; Greulich, Heidi; Kaplan, Bethany et al. (2014) Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. J Clin Invest 124:1582-6|
|Brooks, Angela N; Choi, Peter S; de Waal, Luc et al. (2014) A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS One 9:e87361|
|Schwarz, Benjamin A; Bar-Nur, Ori; Silva, José C R et al. (2014) Nanog is dispensable for the generation of induced pluripotent stem cells. Curr Biol 24:347-50|
|Joung, J Keith; Sander, Jeffry D (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14:49-55|
|Gupta, Nitin K; Masia, Ricard (2013) Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract. Am J Surg Pathol 37:1109-13|
|Li, Xianghong; Burnight, Erin R; Cooney, Ashley L et al. (2013) piggyBac transposase tools for genome engineering. Proc Natl Acad Sci U S A 110:E2279-87|
|Maeder, Morgan L; Linder, Samantha J; Reyon, Deepak et al. (2013) Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 10:243-5|
|Sander, Jeffry D; Ramirez, Cherie L; Linder, Samantha J et al. (2013) In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites. Nucleic Acids Res 41:e181|
Showing the most recent 10 out of 84 publications